StockWatch
·

Indogulf Cropsciences Ltd

BSE: 544432

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
163.80
+18.9%-12.0%
Expenditure
160.89
+31.3%-11.9%
Net Profit
2.27
-81.2%-23.2%
OPM %
5.31%
-9.72pp+0.63pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0069.56139.13208.69278.25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Shareholding Trend

PromoterPublic
0%50%100%Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Latest News
Quarterly Result12 Aug, 11:51 am

Indogulf Q1 FY27: consolidated PAT down 38% YoY as margins compress to 1.4%

Indogulf Cropsciences reported consolidated Q1 FY27 (quarter ended June 30, 2026) revenue of ₹168.5 Cr, down 11.0% YoY from ₹189.4 Cr, though up 11.8% sequentially from ₹150.8 Cr in Q4 FY26. Consolidated PAT fell to ₹2.41 Cr — down 37.6% YoY from ₹3.87 Cr and down 79.2% QoQ from ₹11.61 Cr — with basic EPS at ₹0.38 versus ₹0.80 a year ago and ₹2.30 in the preceding quarter. Standalone PAT of ₹2.27 Cr fell a comparatively smaller 23.2% YoY (standalone revenue -12.3% YoY to ₹162.4 Cr), so the wider consolidated decline signals a weaker contribution from the two subsidiaries, Abhiprakash Globus Private Limited and Indogulf Cropsciences Australia Pty Ltd, versus a year ago. Net profit margin compressed to 1.43% of total income from 2.03% a year ago and 7.60% in Q4 FY26 — the compression shows up even as revenue grew sequentially, so the pressure is on the cost side rather than volumes. No single expense line stands out as an outlier; the combined weight of raw-material, employee and other operating costs against a YoY-softer topline drove the squeeze. Exceptional items were negligible (~₹3 lakh, both this quarter and a year ago) and were not a factor. No formal analyst consensus or brokerage preview for this print turned up in a web search — Indogulf is a recently listed small-cap without established sell-side coverage, so vsStreet is unknown. The results were approved at the August 12, 2026 board meeting alongside a separate IPO fund-utilization report for the quarter, filed the same day; auditors issued an unmodified limited-review opinion on both statements. No standalone management press release accompanied the filing beyond the board-outcome letter, so there is no additional management commentary to reconcile against the print. The quarter directly confirms management's May 2026 caution that FY27 would see "near-term volatility from weather, inventory corrections, and input costs" ahead of an anticipated stabilization from firming prices and a richer product mix — Q1's YoY revenue decline and sharp margin compression validate that near-term-weak framing (guidance met, in the sense of confirming the warned volatility). The promised price/mix-driven margin recovery is now the marker to verify from Q2 onward.

12 Aug 2026, 11:51 am

Corporate Events

Board MeetingIGCL
2026
24Sep

Board Meeting

The 34th Annual General Meeting (AGM) of Indogulf Cropscienc…

BSE Filing
Board MeetingIGCL
2026
12Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing
Board MeetingIGCL
2026
28May

Board Meeting

To consider and approve the Audited Standalone and Consolida…

BSE Filing